Literature DB >> 415609

Hyperbilirubinemia and cholestasis.

P D Berk, N B Javitt.   

Abstract

Although the morphologist continues to describe cholestasis on the basis of precipitated bile seen on light microscopic sections of the liver or dilated canaliculi with loss of microvilli seen by electron microscopy, the physiologist can distinguish clearly between hyperbilirubinemia and cholestasis. Both bilirubin and bile acids are specifically removed from sinusoidal plasma by the normal hepatocyte and appear in bile in high concentration. Bilirubin conjugation and excretion appear to be governed by hepatocellular mechanisms that are, for the most part, separate from the conjugation and excretion of bile acids. Disturbances in bilirubin transport are recognized by hyperbilirubinemia which represents a number of clinical syndromes that can be classified by the nature of the block in the transport system. Serum bile acids appear to remain normal in hyperbilirubinemic syndromes. By contrast, cholestatic syndromes are characterized by marked bile acidemia with normal to slightly elevated bilirubin levels. Severe cholestasis, because of the marked reduction in bile flow, can however, engender jaundice. Further exploration of these excretory pathways will provide interesting new insights on the numerous cholestatic and hyperbilirubinemic syndromes that occur in nature.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415609     DOI: 10.1016/0002-9343(78)90061-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 2.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

3.  Fermentable fibers induce rapid macro- and micronutrient depletion in Toll-like receptor 5-deficient mice.

Authors:  Rachel M Golonka; Beng San Yeoh; Yaqi Li; Piu Saha; Ahmed A Abokor; Xi Cheng; Xia Xiao; Darshan Shimoga Chandrashekar; Sooryanarayana Varambally; David J Gonzalez; A Catharine Ross; Matam Vijay-Kumar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-03-23       Impact factor: 4.052

4.  Current challenges and controversies in drug-induced liver injury.

Authors:  Alberto Corsini; Patricia Ganey; Cynthia Ju; Neil Kaplowitz; Dominique Pessayre; Robert Roth; Paul B Watkins; Mudher Albassam; Baolian Liu; Saray Stancic; Laura Suter; Michele Bortolini
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

5.  Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Surg Neurol Int       Date:  2015-03-24

6.  Familial intrahepatic cholestasis: an update.

Authors:  C A Riely
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb

7.  Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity.

Authors:  Andreas Buness; Adrian Roth; Annika Herrmann; Oliver Schmitz; Hennicke Kamp; Kristina Busch; Laura Suter
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.